Medicine (Oxford)

, volume 36 , issue 1 , pages 24-28

Cytotoxic chemotherapy: clinical aspects

Pippa G Corrie

Pippa G. Corrie

Publication type: Journal Article

Publication date: 2008-01-09

Elsevier

Medicine (Oxford)

scimago Q4

SJR: 0.196

CiteScore: 1.0

Impact factor: —

ISSN: 13573039, 18789390

DOI: 10.1016/j.mpmed.2007.10.012

Copy DOI

General Medicine

Abstract

Cytotoxic chemotherapy drugs primarily damage proliferating cells and we now know the molecular target of most of the drugs in clinical use. Even so, non-specificity of cytotoxic agents is a major drawback and potential to damage normal tissues means that cure with chemotherapy is not often achieved. With advances in science, rational drug design is now becoming a reality, but these mechanism-driven, targeted agents are likely to be additions to, rather than substitutes for, conventional chemotherapy drugs. As cancer treatment becomes increasingly complex, the challenge for clinicians and scientists now is to manipulate our treatments to maximize benefit and minimize harm for the individual patient.

Found

1 citation

Fedorov Alexey

DSc in Chemistry, associate member of the Russian Academy of Sciences

93 publications, 2 863 citations, 10 reviews

h-index: 27

Lobachevsky State University of Nizhny Novgorod

1 citation

Nyuchev Alexander

🥼 🤝

PhD in Chemistry

43 publications, 1 279 citations, 27 reviews

h-index: 19

Lobachevsky State University of Nizhny Novgorod

Research interests

Flow Chemistry

Flow-through microreactors

Top-30

Journals

	1 2 3 4
Journal of Molecular Structure	Journal of Molecular Structure, 4, 2.37% Journal of Molecular Structure 4 publications, 2.37%
Molecules	Molecules, 3, 1.78% Molecules 3 publications, 1.78%
Journal of Drug Delivery Science and Technology	Journal of Drug Delivery Science and Technology, 3, 1.78% Journal of Drug Delivery Science and Technology 3 publications, 1.78%
European Journal of Pharmacology	European Journal of Pharmacology, 3, 1.78% European Journal of Pharmacology 3 publications, 1.78%
RSC Advances	RSC Advances, 3, 1.78% RSC Advances 3 publications, 1.78%
New Journal of Chemistry	New Journal of Chemistry, 3, 1.78% New Journal of Chemistry 3 publications, 1.78%
Pharmaceutics	Pharmaceutics, 2, 1.18% Pharmaceutics 2 publications, 1.18%
Oncology Letters	Oncology Letters, 2, 1.18% Oncology Letters 2 publications, 1.18%
Nutrients	Nutrients, 2, 1.18% Nutrients 2 publications, 1.18%
Nanomaterials	Nanomaterials, 2, 1.18% Nanomaterials 2 publications, 1.18%
Colloids and Surfaces B: Biointerfaces	Colloids and Surfaces B: Biointerfaces, 2, 1.18% Colloids and Surfaces B: Biointerfaces 2 publications, 1.18%
Biomedicine and Pharmacotherapy	Biomedicine and Pharmacotherapy, 2, 1.18% Biomedicine and Pharmacotherapy 2 publications, 1.18%
Bioorganic Chemistry	Bioorganic Chemistry, 2, 1.18% Bioorganic Chemistry 2 publications, 1.18%
Advanced healthcare materials	Advanced healthcare materials, 2, 1.18% Advanced healthcare materials 2 publications, 1.18%
Angewandte Chemie - International Edition	Angewandte Chemie - International Edition, 2, 1.18% Angewandte Chemie - International Edition 2 publications, 1.18%
Angewandte Chemie	Angewandte Chemie, 2, 1.18% Angewandte Chemie 2 publications, 1.18%
Advanced Materials	Advanced Materials, 2, 1.18% Advanced Materials 2 publications, 1.18%
ACS applied materials & interfaces	ACS applied materials & interfaces, 2, 1.18% ACS applied materials & interfaces 2 publications, 1.18%
ACS Applied Bio Materials	ACS Applied Bio Materials, 2, 1.18% ACS Applied Bio Materials 2 publications, 1.18%
ACS Omega	ACS Omega, 2, 1.18% ACS Omega 2 publications, 1.18%
ACS Applied Nano Materials	ACS Applied Nano Materials, 2, 1.18% ACS Applied Nano Materials 2 publications, 1.18%
Journal of Medicinal Chemistry	Journal of Medicinal Chemistry, 1, 0.59% Journal of Medicinal Chemistry 1 publication, 0.59%
Biomolecules and Therapeutics	Biomolecules and Therapeutics, 1, 0.59% Biomolecules and Therapeutics 1 publication, 0.59%
Journal of Biomechanical Engineering	Journal of Biomechanical Engineering, 1, 0.59% Journal of Biomechanical Engineering 1 publication, 0.59%
Biointerphases	Biointerphases, 1, 0.59% Biointerphases 1 publication, 0.59%
Current Pharmaceutical Design	Current Pharmaceutical Design, 1, 0.59% Current Pharmaceutical Design 1 publication, 0.59%
Nanomedicine	Nanomedicine, 1, 0.59% Nanomedicine 1 publication, 0.59%
Journal of Intelligent and Fuzzy Systems	Journal of Intelligent and Fuzzy Systems, 1, 0.59% Journal of Intelligent and Fuzzy Systems 1 publication, 0.59%
Nano LIFE	Nano LIFE, 1, 0.59% Nano LIFE 1 publication, 0.59%
	1 2 3 4

Publishers

	5 10 15 20 25 30 35 40 45
Elsevier	Elsevier, 45, 26.63% Elsevier 45 publications, 26.63%
Wiley	Wiley, 23, 13.61% Wiley 23 publications, 13.61%
Springer Nature	Springer Nature, 16, 9.47% Springer Nature 16 publications, 9.47%
MDPI	MDPI, 15, 8.88% MDPI 15 publications, 8.88%
American Chemical Society (ACS)	American Chemical Society (ACS), 13, 7.69% American Chemical Society (ACS) 13 publications, 7.69%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 10, 5.92% Royal Society of Chemistry (RSC) 10 publications, 5.92%
Taylor & Francis	Taylor & Francis, 9, 5.33% Taylor & Francis 9 publications, 5.33%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 4, 2.37% Cold Spring Harbor Laboratory 4 publications, 2.37%
Pleiades Publishing	Pleiades Publishing, 3, 1.78% Pleiades Publishing 3 publications, 1.78%
Bentham Science Publishers Ltd.	Bentham Science Publishers Ltd., 2, 1.18% Bentham Science Publishers Ltd. 2 publications, 1.18%
Spandidos Publications	Spandidos Publications, 2, 1.18% Spandidos Publications 2 publications, 1.18%
SAGE	SAGE, 2, 1.18% SAGE 2 publications, 1.18%
Frontiers Media S.A.	Frontiers Media S.A., 2, 1.18% Frontiers Media S.A. 2 publications, 1.18%
Korean Society of Applied Pharmacology	Korean Society of Applied Pharmacology, 1, 0.59% Korean Society of Applied Pharmacology 1 publication, 0.59%
ASME International	ASME International, 1, 0.59% ASME International 1 publication, 0.59%
American Vacuum Society	American Vacuum Society, 1, 0.59% American Vacuum Society 1 publication, 0.59%
IOS Press	IOS Press, 1, 0.59% IOS Press 1 publication, 0.59%
World Scientific	World Scientific, 1, 0.59% World Scientific 1 publication, 0.59%
The Electrochemical Society	The Electrochemical Society, 1, 0.59% The Electrochemical Society 1 publication, 0.59%
Pensoft Publishers	Pensoft Publishers, 1, 0.59% Pensoft Publishers 1 publication, 0.59%
Public Library of Science (PLoS)	Public Library of Science (PLoS), 1, 0.59% Public Library of Science (PLoS) 1 publication, 0.59%
Federation of American Societies for Experimental Biology (FASEB)	Federation of American Societies for Experimental Biology (FASEB), 1, 0.59% Federation of American Societies for Experimental Biology (FASEB) 1 publication, 0.59%
BMJ	BMJ, 1, 0.59% BMJ 1 publication, 0.59%
Association for Computing Machinery (ACM)	Association for Computing Machinery (ACM), 1, 0.59% Association for Computing Machinery (ACM) 1 publication, 0.59%
Scientific Research Publishing	Scientific Research Publishing, 1, 0.59% Scientific Research Publishing 1 publication, 0.59%
Walter de Gruyter	Walter de Gruyter, 1, 0.59% Walter de Gruyter 1 publication, 0.59%
Publishing House Belorusskaya Nauka	Publishing House Belorusskaya Nauka, 1, 0.59% Publishing House Belorusskaya Nauka 1 publication, 0.59%
Institute of Electrical and Electronics Engineers (IEEE)	Institute of Electrical and Electronics Engineers (IEEE), 1, 0.59% Institute of Electrical and Electronics Engineers (IEEE) 1 publication, 0.59%
Optica Publishing Group	Optica Publishing Group, 1, 0.59% Optica Publishing Group 1 publication, 0.59%
	5 10 15 20 25 30 35 40 45

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

169

Cite this

GOST |

Cite this

GOST Copy

Corrie P. G., Corrie P. G. Cytotoxic chemotherapy: clinical aspects // Medicine (Oxford). 2008. Vol. 36. No. 1. pp. 24-28.

GOST all authors (up to 50) Copy

Corrie P. G., Corrie P. G. Cytotoxic chemotherapy: clinical aspects // Medicine (Oxford). 2008. Vol. 36. No. 1. pp. 24-28.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1016/j.mpmed.2007.10.012

UR - https://doi.org/10.1016/j.mpmed.2007.10.012

TI - Cytotoxic chemotherapy: clinical aspects

T2 - Medicine (Oxford)

AU - Corrie, Pippa G

AU - Corrie, Pippa G.

PY - 2008

DA - 2008/01/09

PB - Elsevier

SP - 24-28

IS - 1

VL - 36

SN - 1357-3039

SN - 1878-9390

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2008_Corrie,

author = {Pippa G Corrie and Pippa G. Corrie},

title = {Cytotoxic chemotherapy: clinical aspects},

journal = {Medicine (Oxford)},

year = {2008},

volume = {36},

publisher = {Elsevier},

month = {jan},

url = {https://doi.org/10.1016/j.mpmed.2007.10.012},

number = {1},

pages = {24--28},

doi = {10.1016/j.mpmed.2007.10.012}

}

MLA

Cite this

MLA Copy

Corrie, Pippa G., and Pippa G. Corrie. “Cytotoxic chemotherapy: clinical aspects.” Medicine (Oxford), vol. 36, no. 1, Jan. 2008, pp. 24-28. https://doi.org/10.1016/j.mpmed.2007.10.012.

Publisher

Elsevier

Journal

Medicine (Oxford)

scimago Q4

SJR

0.196

CiteScore

1.0

Impact factor

—

ISSN

13573039 (Print)

18789390 (Electronic)